Highly delayed systemic translocation of aluminum-based adjuvant in CD1 mice following intramuscular injections

Concerns regarding vaccine safety have emerged following reports of potential adverse events in both humans and animals. In the present study, alum, alum-containing vaccine and alum adjuvant tagged with fluorescent nanodiamonds were used to evaluate i) the persistence time at the injection site, ii)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of inorganic biochemistry 2015-11, Vol.152, p.199-205
Hauptverfasser: Crépeaux, Guillemette, Eidi, Housam, David, Marie-Odile, Tzavara, Eleni, Giros, Bruno, Exley, Christopher, Curmi, Patrick A., Shaw, Christopher A., Gherardi, Romain K., Cadusseau, Josette
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 205
container_issue
container_start_page 199
container_title Journal of inorganic biochemistry
container_volume 152
creator Crépeaux, Guillemette
Eidi, Housam
David, Marie-Odile
Tzavara, Eleni
Giros, Bruno
Exley, Christopher
Curmi, Patrick A.
Shaw, Christopher A.
Gherardi, Romain K.
Cadusseau, Josette
description Concerns regarding vaccine safety have emerged following reports of potential adverse events in both humans and animals. In the present study, alum, alum-containing vaccine and alum adjuvant tagged with fluorescent nanodiamonds were used to evaluate i) the persistence time at the injection site, ii) the translocation of alum from the injection site to lymphoid organs, and iii) the behavior of adult CD1 mice following intramuscular injection of alum (400μgAl/kg). Results showed for the first time a strikingly delayed systemic translocation of adjuvant particles. Alum-induced granuloma remained for a very long time in the injected muscle despite progressive shrinkage from day 45 to day 270. Concomitantly, a markedly delayed translocation of alum to the draining lymph nodes, major at day 270 endpoint, was observed. Translocation to the spleen was similarly delayed (highest number of particles at day 270). In contrast to C57BL/6J mice, no brain translocation of alum was observed by day 270 in CD1 mice. Consistently neither increase of Al cerebral content, nor behavioral changes were observed. On the basis of previous reports showing alum neurotoxic effects in CD1 mice, an additional experiment was done, and showed early brain translocation at day 45 of alum injected subcutaneously at 200μgAl/kg. This study confirms the striking biopersistence of alum. It points out an unexpectedly delayed diffusion of the adjuvant in lymph nodes and spleen of CD1 mice, and suggests the importance of mouse strain, route of administration, and doses, for future studies focusing on the potential toxic effects of aluminum-based adjuvants. [Display omitted] •Vaccine safety is a key question due to the reported adverse events in humans & animals.•Results showed a highly delayed systemic translocation of adjuvant particles.•This study suggests the importance of mouse strain, route of exposure & doses.•This study confirms the striking biopersistence of alum.
doi_str_mv 10.1016/j.jinorgbio.2015.07.004
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_02292714v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0162013415300313</els_id><sourcerecordid>1749998667</sourcerecordid><originalsourceid>FETCH-LOGICAL-c405t-9bebce9f0b7bdbe9d1998991f8d7276fd146594d004dafec0330514668a8e6d03</originalsourceid><addsrcrecordid>eNqFkUGv1CAUhYnR-Manf0FZ6qIVCi1lOZmnjskkbnRNKNzOo6HwhHbM_HuZzHO2rgg33zkH7kHoAyU1JbT7PNWTCzEdBxfrhtC2JqImhL9AG9oLVjHG-Uu0KWRTEcr4HXqT80QIaVsuXqO7pmM950xsUNy746M_Ywten8HifM4LzM7gJemQfTR6cTHgOGLt19mFda4GnQuo7bSedFiwC3j3QHHRAB6j9_GPC8cyLQbzms3qdSq3CczFKL9Fr0btM7x7Pu_Rr69ffu721eHHt--77aEynLRLJQcYDMiRDGKwA0hLpeylpGNvRSO60VLetZLb8merRzCEMdKWWdfrHjpL2D36dPV91F49JTfrdFZRO7XfHtRlRppGNoLyEy3sxyv7lOLvFfKiZpcNeK8DxDUrKrgs8V0nCiquqEkx5wTjzZsSdWlGTerWjLo0o4hQ5ZVF-f45ZB1msDfdvyoKsL0CUNZycpBUNg6CAetSWZ6y0f035C97zqVQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1749998667</pqid></control><display><type>article</type><title>Highly delayed systemic translocation of aluminum-based adjuvant in CD1 mice following intramuscular injections</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Crépeaux, Guillemette ; Eidi, Housam ; David, Marie-Odile ; Tzavara, Eleni ; Giros, Bruno ; Exley, Christopher ; Curmi, Patrick A. ; Shaw, Christopher A. ; Gherardi, Romain K. ; Cadusseau, Josette</creator><creatorcontrib>Crépeaux, Guillemette ; Eidi, Housam ; David, Marie-Odile ; Tzavara, Eleni ; Giros, Bruno ; Exley, Christopher ; Curmi, Patrick A. ; Shaw, Christopher A. ; Gherardi, Romain K. ; Cadusseau, Josette</creatorcontrib><description>Concerns regarding vaccine safety have emerged following reports of potential adverse events in both humans and animals. In the present study, alum, alum-containing vaccine and alum adjuvant tagged with fluorescent nanodiamonds were used to evaluate i) the persistence time at the injection site, ii) the translocation of alum from the injection site to lymphoid organs, and iii) the behavior of adult CD1 mice following intramuscular injection of alum (400μgAl/kg). Results showed for the first time a strikingly delayed systemic translocation of adjuvant particles. Alum-induced granuloma remained for a very long time in the injected muscle despite progressive shrinkage from day 45 to day 270. Concomitantly, a markedly delayed translocation of alum to the draining lymph nodes, major at day 270 endpoint, was observed. Translocation to the spleen was similarly delayed (highest number of particles at day 270). In contrast to C57BL/6J mice, no brain translocation of alum was observed by day 270 in CD1 mice. Consistently neither increase of Al cerebral content, nor behavioral changes were observed. On the basis of previous reports showing alum neurotoxic effects in CD1 mice, an additional experiment was done, and showed early brain translocation at day 45 of alum injected subcutaneously at 200μgAl/kg. This study confirms the striking biopersistence of alum. It points out an unexpectedly delayed diffusion of the adjuvant in lymph nodes and spleen of CD1 mice, and suggests the importance of mouse strain, route of administration, and doses, for future studies focusing on the potential toxic effects of aluminum-based adjuvants. [Display omitted] •Vaccine safety is a key question due to the reported adverse events in humans &amp; animals.•Results showed a highly delayed systemic translocation of adjuvant particles.•This study suggests the importance of mouse strain, route of exposure &amp; doses.•This study confirms the striking biopersistence of alum.</description><identifier>ISSN: 0162-0134</identifier><identifier>EISSN: 1873-3344</identifier><identifier>DOI: 10.1016/j.jinorgbio.2015.07.004</identifier><identifier>PMID: 26384437</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adjuvants, Immunologic - administration &amp; dosage ; Adjuvants, Immunologic - blood ; Adjuvants, Immunologic - toxicity ; Alum ; Aluminum Compounds - administration &amp; dosage ; Aluminum Compounds - blood ; Aluminum Compounds - toxicity ; Animals ; CD1 mice ; Delayed-translocation ; Female ; Fluorescent-nanodiamonds ; Granuloma - etiology ; Injections, Intramuscular ; Life Sciences ; Mice ; Neurons and Cognition ; Neurotoxicity ; Species Specificity ; Vaccine-adjuvant</subject><ispartof>Journal of inorganic biochemistry, 2015-11, Vol.152, p.199-205</ispartof><rights>2015 Elsevier Inc.</rights><rights>Copyright © 2015 Elsevier Inc. All rights reserved.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c405t-9bebce9f0b7bdbe9d1998991f8d7276fd146594d004dafec0330514668a8e6d03</citedby><cites>FETCH-LOGICAL-c405t-9bebce9f0b7bdbe9d1998991f8d7276fd146594d004dafec0330514668a8e6d03</cites><orcidid>0000-0001-7624-3904 ; 0000-0002-4543-7818 ; 0000-0001-5045-8501 ; 0000-0001-5876-9822</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0162013415300313$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26384437$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://univ-evry.hal.science/hal-02292714$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Crépeaux, Guillemette</creatorcontrib><creatorcontrib>Eidi, Housam</creatorcontrib><creatorcontrib>David, Marie-Odile</creatorcontrib><creatorcontrib>Tzavara, Eleni</creatorcontrib><creatorcontrib>Giros, Bruno</creatorcontrib><creatorcontrib>Exley, Christopher</creatorcontrib><creatorcontrib>Curmi, Patrick A.</creatorcontrib><creatorcontrib>Shaw, Christopher A.</creatorcontrib><creatorcontrib>Gherardi, Romain K.</creatorcontrib><creatorcontrib>Cadusseau, Josette</creatorcontrib><title>Highly delayed systemic translocation of aluminum-based adjuvant in CD1 mice following intramuscular injections</title><title>Journal of inorganic biochemistry</title><addtitle>J Inorg Biochem</addtitle><description>Concerns regarding vaccine safety have emerged following reports of potential adverse events in both humans and animals. In the present study, alum, alum-containing vaccine and alum adjuvant tagged with fluorescent nanodiamonds were used to evaluate i) the persistence time at the injection site, ii) the translocation of alum from the injection site to lymphoid organs, and iii) the behavior of adult CD1 mice following intramuscular injection of alum (400μgAl/kg). Results showed for the first time a strikingly delayed systemic translocation of adjuvant particles. Alum-induced granuloma remained for a very long time in the injected muscle despite progressive shrinkage from day 45 to day 270. Concomitantly, a markedly delayed translocation of alum to the draining lymph nodes, major at day 270 endpoint, was observed. Translocation to the spleen was similarly delayed (highest number of particles at day 270). In contrast to C57BL/6J mice, no brain translocation of alum was observed by day 270 in CD1 mice. Consistently neither increase of Al cerebral content, nor behavioral changes were observed. On the basis of previous reports showing alum neurotoxic effects in CD1 mice, an additional experiment was done, and showed early brain translocation at day 45 of alum injected subcutaneously at 200μgAl/kg. This study confirms the striking biopersistence of alum. It points out an unexpectedly delayed diffusion of the adjuvant in lymph nodes and spleen of CD1 mice, and suggests the importance of mouse strain, route of administration, and doses, for future studies focusing on the potential toxic effects of aluminum-based adjuvants. [Display omitted] •Vaccine safety is a key question due to the reported adverse events in humans &amp; animals.•Results showed a highly delayed systemic translocation of adjuvant particles.•This study suggests the importance of mouse strain, route of exposure &amp; doses.•This study confirms the striking biopersistence of alum.</description><subject>Adjuvants, Immunologic - administration &amp; dosage</subject><subject>Adjuvants, Immunologic - blood</subject><subject>Adjuvants, Immunologic - toxicity</subject><subject>Alum</subject><subject>Aluminum Compounds - administration &amp; dosage</subject><subject>Aluminum Compounds - blood</subject><subject>Aluminum Compounds - toxicity</subject><subject>Animals</subject><subject>CD1 mice</subject><subject>Delayed-translocation</subject><subject>Female</subject><subject>Fluorescent-nanodiamonds</subject><subject>Granuloma - etiology</subject><subject>Injections, Intramuscular</subject><subject>Life Sciences</subject><subject>Mice</subject><subject>Neurons and Cognition</subject><subject>Neurotoxicity</subject><subject>Species Specificity</subject><subject>Vaccine-adjuvant</subject><issn>0162-0134</issn><issn>1873-3344</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUGv1CAUhYnR-Manf0FZ6qIVCi1lOZmnjskkbnRNKNzOo6HwhHbM_HuZzHO2rgg33zkH7kHoAyU1JbT7PNWTCzEdBxfrhtC2JqImhL9AG9oLVjHG-Uu0KWRTEcr4HXqT80QIaVsuXqO7pmM950xsUNy746M_Ywten8HifM4LzM7gJemQfTR6cTHgOGLt19mFda4GnQuo7bSedFiwC3j3QHHRAB6j9_GPC8cyLQbzms3qdSq3CczFKL9Fr0btM7x7Pu_Rr69ffu721eHHt--77aEynLRLJQcYDMiRDGKwA0hLpeylpGNvRSO60VLetZLb8merRzCEMdKWWdfrHjpL2D36dPV91F49JTfrdFZRO7XfHtRlRppGNoLyEy3sxyv7lOLvFfKiZpcNeK8DxDUrKrgs8V0nCiquqEkx5wTjzZsSdWlGTerWjLo0o4hQ5ZVF-f45ZB1msDfdvyoKsL0CUNZycpBUNg6CAetSWZ6y0f035C97zqVQ</recordid><startdate>201511</startdate><enddate>201511</enddate><creator>Crépeaux, Guillemette</creator><creator>Eidi, Housam</creator><creator>David, Marie-Odile</creator><creator>Tzavara, Eleni</creator><creator>Giros, Bruno</creator><creator>Exley, Christopher</creator><creator>Curmi, Patrick A.</creator><creator>Shaw, Christopher A.</creator><creator>Gherardi, Romain K.</creator><creator>Cadusseau, Josette</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0001-7624-3904</orcidid><orcidid>https://orcid.org/0000-0002-4543-7818</orcidid><orcidid>https://orcid.org/0000-0001-5045-8501</orcidid><orcidid>https://orcid.org/0000-0001-5876-9822</orcidid></search><sort><creationdate>201511</creationdate><title>Highly delayed systemic translocation of aluminum-based adjuvant in CD1 mice following intramuscular injections</title><author>Crépeaux, Guillemette ; Eidi, Housam ; David, Marie-Odile ; Tzavara, Eleni ; Giros, Bruno ; Exley, Christopher ; Curmi, Patrick A. ; Shaw, Christopher A. ; Gherardi, Romain K. ; Cadusseau, Josette</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c405t-9bebce9f0b7bdbe9d1998991f8d7276fd146594d004dafec0330514668a8e6d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adjuvants, Immunologic - administration &amp; dosage</topic><topic>Adjuvants, Immunologic - blood</topic><topic>Adjuvants, Immunologic - toxicity</topic><topic>Alum</topic><topic>Aluminum Compounds - administration &amp; dosage</topic><topic>Aluminum Compounds - blood</topic><topic>Aluminum Compounds - toxicity</topic><topic>Animals</topic><topic>CD1 mice</topic><topic>Delayed-translocation</topic><topic>Female</topic><topic>Fluorescent-nanodiamonds</topic><topic>Granuloma - etiology</topic><topic>Injections, Intramuscular</topic><topic>Life Sciences</topic><topic>Mice</topic><topic>Neurons and Cognition</topic><topic>Neurotoxicity</topic><topic>Species Specificity</topic><topic>Vaccine-adjuvant</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Crépeaux, Guillemette</creatorcontrib><creatorcontrib>Eidi, Housam</creatorcontrib><creatorcontrib>David, Marie-Odile</creatorcontrib><creatorcontrib>Tzavara, Eleni</creatorcontrib><creatorcontrib>Giros, Bruno</creatorcontrib><creatorcontrib>Exley, Christopher</creatorcontrib><creatorcontrib>Curmi, Patrick A.</creatorcontrib><creatorcontrib>Shaw, Christopher A.</creatorcontrib><creatorcontrib>Gherardi, Romain K.</creatorcontrib><creatorcontrib>Cadusseau, Josette</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Journal of inorganic biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Crépeaux, Guillemette</au><au>Eidi, Housam</au><au>David, Marie-Odile</au><au>Tzavara, Eleni</au><au>Giros, Bruno</au><au>Exley, Christopher</au><au>Curmi, Patrick A.</au><au>Shaw, Christopher A.</au><au>Gherardi, Romain K.</au><au>Cadusseau, Josette</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Highly delayed systemic translocation of aluminum-based adjuvant in CD1 mice following intramuscular injections</atitle><jtitle>Journal of inorganic biochemistry</jtitle><addtitle>J Inorg Biochem</addtitle><date>2015-11</date><risdate>2015</risdate><volume>152</volume><spage>199</spage><epage>205</epage><pages>199-205</pages><issn>0162-0134</issn><eissn>1873-3344</eissn><abstract>Concerns regarding vaccine safety have emerged following reports of potential adverse events in both humans and animals. In the present study, alum, alum-containing vaccine and alum adjuvant tagged with fluorescent nanodiamonds were used to evaluate i) the persistence time at the injection site, ii) the translocation of alum from the injection site to lymphoid organs, and iii) the behavior of adult CD1 mice following intramuscular injection of alum (400μgAl/kg). Results showed for the first time a strikingly delayed systemic translocation of adjuvant particles. Alum-induced granuloma remained for a very long time in the injected muscle despite progressive shrinkage from day 45 to day 270. Concomitantly, a markedly delayed translocation of alum to the draining lymph nodes, major at day 270 endpoint, was observed. Translocation to the spleen was similarly delayed (highest number of particles at day 270). In contrast to C57BL/6J mice, no brain translocation of alum was observed by day 270 in CD1 mice. Consistently neither increase of Al cerebral content, nor behavioral changes were observed. On the basis of previous reports showing alum neurotoxic effects in CD1 mice, an additional experiment was done, and showed early brain translocation at day 45 of alum injected subcutaneously at 200μgAl/kg. This study confirms the striking biopersistence of alum. It points out an unexpectedly delayed diffusion of the adjuvant in lymph nodes and spleen of CD1 mice, and suggests the importance of mouse strain, route of administration, and doses, for future studies focusing on the potential toxic effects of aluminum-based adjuvants. [Display omitted] •Vaccine safety is a key question due to the reported adverse events in humans &amp; animals.•Results showed a highly delayed systemic translocation of adjuvant particles.•This study suggests the importance of mouse strain, route of exposure &amp; doses.•This study confirms the striking biopersistence of alum.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26384437</pmid><doi>10.1016/j.jinorgbio.2015.07.004</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-7624-3904</orcidid><orcidid>https://orcid.org/0000-0002-4543-7818</orcidid><orcidid>https://orcid.org/0000-0001-5045-8501</orcidid><orcidid>https://orcid.org/0000-0001-5876-9822</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0162-0134
ispartof Journal of inorganic biochemistry, 2015-11, Vol.152, p.199-205
issn 0162-0134
1873-3344
language eng
recordid cdi_hal_primary_oai_HAL_hal_02292714v1
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adjuvants, Immunologic - administration & dosage
Adjuvants, Immunologic - blood
Adjuvants, Immunologic - toxicity
Alum
Aluminum Compounds - administration & dosage
Aluminum Compounds - blood
Aluminum Compounds - toxicity
Animals
CD1 mice
Delayed-translocation
Female
Fluorescent-nanodiamonds
Granuloma - etiology
Injections, Intramuscular
Life Sciences
Mice
Neurons and Cognition
Neurotoxicity
Species Specificity
Vaccine-adjuvant
title Highly delayed systemic translocation of aluminum-based adjuvant in CD1 mice following intramuscular injections
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T15%3A05%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Highly%20delayed%20systemic%20translocation%20of%20aluminum-based%20adjuvant%20in%20CD1%20mice%20following%20intramuscular%20injections&rft.jtitle=Journal%20of%20inorganic%20biochemistry&rft.au=Cr%C3%A9peaux,%20Guillemette&rft.date=2015-11&rft.volume=152&rft.spage=199&rft.epage=205&rft.pages=199-205&rft.issn=0162-0134&rft.eissn=1873-3344&rft_id=info:doi/10.1016/j.jinorgbio.2015.07.004&rft_dat=%3Cproquest_hal_p%3E1749998667%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1749998667&rft_id=info:pmid/26384437&rft_els_id=S0162013415300313&rfr_iscdi=true